2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

Abstract

These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea. They are not intended to replace physician judgement regarding specific patients or clinical or public health situations. This document does not provide detailed recommendations on infection prevention and control aspects related to infectious diarrhea.

The GenMark ePlex ® : Another Weapon in the Syndromic Arsenal for Infection Diagnosis

“…Multiplex stool panels were the next to become available with an ability to differentiate among many of the diverse causes of enteritis and colitis (viral, bacterial and parasitic) [13]. Although an explicit species-level diagnosis is often not required for uncomplicated cases of either respiratory or diarrheal illness [14][15][16], these assays can be incredibly valuable in immunocompromised hosts, as well as in patients with severe disease or atypical risk factors. More recently, syndromic panels have been developed for less frequently infected anatomic sites -albeit ones with high associated morbidity -with affected patients most often encountered in emergency department and inpatient settings.…”

Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma

“…Hand hygiene appears to be the cornerstone to reduce transmission of bacteria. [1920] When it comes to healthcare workers, there is no difference in guidelines and should not be prescribed antibiotics with intent of reducing secondary transmission. [20] Normally, patients shed bacteria for up to 4 weeks after acute infection and antibiotics given during the acute phase with prolong the carrier state by altering the normal gut flora.…”

Застосування Азитроміцину В Клінічній Практиці

“…У дитячому віці до найпоширеніших збудників бак-теріальних кишкових інфекцій належать Shigella spp., Campylobacter, Salmonella enterica, Escherichia coli, Vibrio cholerae, Clostridium difficile, Yersinia enterocolitica [13,14].…”

“…При ентеротоксигенних штамах Escherichia coli - упро-довж 3 днів у дозі 10 мг/кг/добу. При холері - застосу-вання упродовж 3 днів у дозі 10 мг/кг/добу або одно-разовий прийом 20 мг/кг [13,14].…”